Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice

  • Lee, Su-Jin; 
  • Oh, Seung-Geun; 
  • Seo, Sang-Wan; 
  • Ahn, Hyun-Jong; 
  • Geum, Dongho; 
  • 외 2명
Citations

WEB OF SCIENCE

38
Citations

SCOPUS

44

초록

Epicutaneously administered chemical antigens like 2,4-dinitrofluorobenzene (DNFB), evoke an atopic dermatitis (AD)-like dermatitis reaction in NC/Nga mice under specific pathogen free (SPF) conditions. Astragalus membranaceus (AM), is a popular herbal medicine used to treat allergic diseases in East Asia: In the present study, we examined whether AM suppress AD-like skin lesions in NC/Nga mice treated with DNFB under SPF conditions. Oral administration of AM to DNFB-treated NC/Nga mice was found to inhibit ear thickness increases and the skin lesions induced by DNFB. Moreover, IFN-gamma production by CD4(+) T cells from the lymph nodes of DNFB-treated NC/Nga mice was significantly inhibited by AM treatment, although levels of IL-4 and total IgE in serum were not. Study findings suggest that AM may suppress the development of AD-like dermatitis in DNFB-treated NC/Nga mice by reducing IFN-gamma production.

키워드

atopic dermatitis; 2,4-dinitrofluorobenzene (DNFB); Astragalus membranaceus; NC/Nga mice; ATOPIC-DERMATITIS; T-CELLS; LESIONS
제목
Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice
저자
Lee, Su-Jin; Oh, Seung-Geun; Seo, Sang-Wan; Ahn, Hyun-Jong; Geum, Dongho; Cho, Jeong-Je; Park, Cheung-Seog
DOI
10.1248/bpb.30.1468
발행일
2007-08
유형
Article
저널명
Biological and Pharmaceutical Bulletin
권
30
호
8
페이지
1468 ~ 1471